Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02233842 · ClinicalTrials.gov registry record
Cognitive Testing of Tobacco Use Measurement Items for Administration With Cancer Patients and Survivors
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 30
- Enrollment target
NCT02233842: Completed study, sponsored by National Cancer Institute (NCI).
NCT02233842 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02233842 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
Background: \- People who have cancer have more medical problems if they smoke. Some studies show that smoking even makes cancer treatment less effective. Researchers want to teach people about how tobacco use affects people after a cancer diagnosis. They want to come up with questions for people who have cancer and who have survived cancer. The questions will be about using cigarettes and other tobacco products and about second-hand smoke. The questions will be used to understand how using tobacco affects people with cancer before, during, and after treatment. This will help doctors plan how to treat people with cancer and create programs to help people quit smoking in the future. Objective: \- To evaluate and refine questions that assess tobacco use. Eligibility: \- Adults age 21 or older who have cancer or are cancer survivors. The cancer can be at any site and any stage. Design: * This study will take about 1 hour. * Participants will meet one-on-one with an interviewer. They will fill out a questionnaire and talk about the questions. Participants will explain how easy or hard it was to answer the questions and how they decided on their answers. * All participants will be asked the same or very similar questions. Specific questions will be based on the participants own experiences with tobacco products. * There will be no follow-up activities.
Interventions
- BEHAVIORAL Participant interview
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2014-09 |
| Est. Completion | 2015-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02233842
The ClinicalTrials.gov registry entry for NCT02233842 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Participant interview is the first listed.
NCT02233842 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02233842 about?
NCT02233842 is a clinical study titled "Cognitive Testing of Tobacco Use Measurement Items for Administration With Cancer Patients and Survivors". Background: \- People who have cancer have more medical problems if they smoke. Some studies show that smoking even makes cancer treatment less effective. Researchers want to teach people about how tobacco use affects people after a cancer diagnosis. They want to come up with questions for people w...
What is the current status of trial NCT02233842?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2014-09. Estimated completion is 2015-08.
What interventions are being tested in trial NCT02233842?
The interventions under investigation include: Participant interview (BEHAVIORAL).
Who is sponsoring clinical trial NCT02233842?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.